- Home ›
- News & Events ›
- News
News
Team members of the Global Health Research Teams present research, April 2024. A…
Jason Rohr, Galla Professor and Chair of the Department of Biological Sciences at the University of Notre Dame, is one of three international winners of the 2024 Frontiers Planet Prize for his research that helps improve public health, agriculture,…
In low- and middle-income countries, anemia reduction efforts are often touted as a way to improve educational outcomes and reduce poverty. A new study, co-authored by a Notre Dame global health economics expert, evaluates the relationship between anemia and school...
A study from the University of Notre Dame has identified a population that is more susceptible to developing a catheter-associated urinary tract infections.
Studies have shown that breastfeeding reduces the risk of asthma, obesity, and type 1 diabetes. It can also reduce the risk of…
Human activity across the globe contributes to the rise in emerging infectious disease, but researchers had not concluded which of these activities, called global change drivers, increases risk the most. …
Adding a pre-ketone supplement — a component of a high-fat, low-carb ketogenic diet — to a type of cancer therapy in a laboratory setting was highly effective for treating prostate cancer, researchers from the University of Notre Dame found.
Between 2008 and 2020, districts across the country of Bangladesh saw a 93% reduction in malaria cases. Today, as the world reflects on the World Malaria Day 2024 theme, “accelerating the fight against malaria for a more equitable world,” researchers...
Jason Rohr, Galla Professor and Chair of the Department of Biological Sciences at the University of Notre Dame, is the United States national champion for the Frontiers Planet Prize,…
Yenupini Joyce Adams, an assistant professor of the practice and the global maternal research lead for the Eck Institute for Global Health, has been recognized by the Indiana Clinical and Translational Sciences Institute (CTSI) as an Emerging Leader. This recognition...
Students from almost every discipline at the University of Notre Dame spent several days preparing presentations on one of the world’s most pressing global health challenges: tuberculosis.
Heidi Beidinger is passionate about science and public health which has fueled her nearly 10-year crusade to get children tested for lead poisoning and help their families remediate lead found in and around their homes. The source of the poisoning…
A study from the University of Notre Dame, Massachusetts General Hospital and the National Institutes of Health has identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery. Published in the Proceedings of the National...
For over 8,000 years, the “white death,” tuberculosis (TB), has plagued humankind. Its effects are described in Biblical verses and appear in mummies from Ancient Egypt. Those infected with Mycobacterium tuberculosis, which causes TB, can now be cured thanks to...
Researchers at the University of Notre Dame are engaging community partners in St. Joseph County, Indiana, to improve access to health care services for pregnant and postpartum women in underserved areas of the community with the Pop Up Pregnancy &...
Although two hundred years have passed since the development of the first antimalaria treatment and over 140 years since…
Karla Gonzalez Serrano, postdoctoral scholar for the University of Notre Dame’s Eck Institute for Global Health, has always wanted to join a team that helps doctors provide better care. …
In India, iron-deficient anemia (IDA) among children less than five years old is on the rise, leading to higher “hidden” morbidity and mortality. IDA causes headaches, fatigue, and developmental delays, including physical and cognitive impairment among children. Anemia prevalence in...
“Paradise in wilderness” is how Rev. John Francis (later Cardinal) O’Hara, C.S.C, described the property today known…
In a new study in NPJ Genomic Medicine, researchers at the University of Notre Dame have found that a largely understudied cell could offer new insight into how the aggressive, primary brain cancer is able to resist immunotherapy.